Close Menu

NEW YORK (GenomeWeb) – Abreos Biosciences and True Diagnostics have agreed to collaborate on the development of point-of-care tests that can validate the identity and activity of biologics and biosimilars for use in cancer, autoimmune diseases, and other chronic illnesses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.